Detailed narrative
Strategic Focus and Market Trends
BrightSpring emphasizes its leadership in Home & Community health services, serving complex patients with high-quality, lower-cost care. The company is positioned to capitalize on key healthcare trends, including home-based care and value-based models, leveraging its scale and disciplined operating model for sustainable growth and operational efficiencies.
Management highlighted the company's focus on patient and provider outcomes, continuous improvement, and best practice sharing to expand impact and provide comparatively lower cost services for complex patients.
Pharmacy Solutions Performance
The Pharmacy Solutions segment demonstrated healthy growth, particularly in specialty and infusion, driven by strong script growth, new LDD wins, and generic utilization. Specialty and infusion revenue grew 36% to $2.6 billion. The company added 4 exclusive and UltraAR LDDs, bringing the total to 153.
Investments in automation across the national pharmacy footprint and geographic expansion, especially in infusion, are key drivers. The Home & Community Pharmacy segment faced an expected 9% revenue decline due to IRA impacts and customer exits but showed underlying operational strength, with profitability up year-over-year excluding IRA.
Provider Services Growth
The Provider Services segment saw significant growth, with Home Healthcare revenue growing 49% to $266 million. This was driven by strong census growth, de novo expansion, preferred MA contracts, and successful integration of acquired Amedisys and LHC branches, which contributed $79 million in revenue and $9 million in adjusted EBITDA in Q1.
Rehab revenue grew 7% to $75 million, and Personal Care revenue grew 4% to $102 million, both showing consistent growth and high patient satisfaction scores.
Operational Efficiencies and AI Investment
The company continues to prioritize operational efficiencies and process improvements, attributing significant savings to these initiatives. Investments in AI and technology are streamlining workflows, such as reducing infusion order intake time from hours to seconds. Over 700 process improvement projects have been completed in the last five years, generating nine figures of savings, which are reinvested into people, IT, and technology systems.
The internal AI team now comprises over 20 people, focusing on leveraging data and analytics for proactive care approaches.
Balance Sheet Strength and Capital Allocation
Following the divestiture of the Community Living business to Savita for $835 million gross cash consideration, BrightSpring significantly strengthened its balance sheet. Net cash proceeds before tax of $811 million were used to reduce leverage to 2.27x as of March 31, 2026, down from 2.99x at year-end 2025.
The company plans to evaluate options for its existing term loan and capital structure, maintaining a disciplined approach to M&A with a focus on strategic tuck-ins and geographic expansion.
Quality Outcomes and Patient Satisfaction
Management highlighted strong quality metrics across all service lines. Over 91% of Home Health branches are 4 stars or greater, with timely initiation of care exceeding 99%. Hospice quality measures are well above the national average, with a CAPS overall rating of 87%.
Patient satisfaction scores are 98% for outpatient rehab and 97% for Home & Community rehab. Pharmacy services reported 99.99% dispensing accuracy, 99% order completeness, and 96% on-time delivery, with specialty pharmacy demonstrating a 92.1% medication possession ratio.